TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...

TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

Barclays analyst Luke Sergott raised the firm’s price target on Avantor (AVTR) to $26 from $25 and keeps an Overweight rating on the shares.

The global protein a resins industry is experiencing unprecedented growth, with projections indicating a significant increase ...

Forsta AP Fonden raised its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 3.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities ...

Wall Street expects flat earnings compared to the year-ago quarter on lower revenues when Avantor, Inc. (AVTR) reports results for the quarter ended December 2024. While this widely-known consensus ...

Highlights,Nisa Investment Advisors LLC increased its stake in Avantor by 917.2% in the fourth quarter.,Market assessments ...

Cell Culture Media MarketThe global cell culture media market is poised for substantial growth, projected to be valued at USD ...

Pacific Northwest grocer New Seasons Market has teamed with nonprofit organization Zero Foodprint to launch the application ...

UBS has recently reduced Avantor Inc (AVTR) stock to Neutral rating, as announced on January 17, 2025, according to Finviz. Earlier, on August 28, 2024, Wells Fargo had initiated the stock to ...

Avantor (NYSE:AVTR – Get Free Report) had its price target lowered by Raymond James from $29.00 to $26.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The ...